Abstract
The activity of cefotaxime, either alone or combined with an aminoglycoside, was determined against 50 isolates of Pseudomonas aeruginosa, of which 50, 33, and 10 were resistant to gentamicin, tobramycin, and amikacin, respectively. Cefotaxime inhibited 34 isolates at a concentration of 16 microgram/ml and all isolates at 128 microgram/ml. The combinations of cefotaxime with gentamicin, tobramycin, and amikacin were synergistic against 30, 17, and 9 isolates, respectively, and no antagonism was observed with any combination. Synergism was obtained at clinically significant antibiotic concentrations for nine isolates with cefotaxime-gentamicin, five isolates with cefotaxime-tobramycin, and nine isolates with cefotaxime-amikacin.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference10 articles.
1. Analysis of the interactions between piperacillin, ticarcillin, or carbenicillin and aminoglycoside antibiotics;Chanbusarakum P.;Antimicrob. Agents Chemother.,1978
2. Activity of HR756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods;Drasar F. A.;J. Antimicrob. Chemother.,1978
3. Three antibiotic regimens in the treatment of infections in febrile granulocytopenic patients with cancer;EORTC International Antimicrobial Therapy Project Group;J. Infect. Dis.,1978
4. Cefotaxime (HR756) a new cephalosporin with exceptional broad-spectrum of activity in vitro;Hamilton-Miller J. M. T.;J. Antimicrob. Chemother.,1978
5. Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin;Klastersky J.;Antimicrob. Agents Chemother.,1975
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献